Buy Rating Affirmed for Airsculpt Technologies Amid Expansion and Cost Control Efforts
Airsculpt Technologies, Inc. (AIRS) Receives a Hold From Piper Sandler
Piper Sandler Keeps Their Hold Rating on Airsculpt Technologies, Inc. (AIRS)
Analysts Have Conflicting Sentiments on These Healthcare Companies: Airsculpt Technologies, Inc. (AIRS), Vir Biotechnology (VIR) and Gilead Sciences (GILD)
AirSculpt Technologies Analyst Ratings
Morgan Stanley Maintains Equal-Weight on AirSculpt Technologies, Raises Price Target to $8
AirSculpt Technologies Analyst Ratings
Morgan Stanley Maintains Equal-Weight on AirSculpt Technologies, Raises Price Target to $8
AirSculpt Technologies Analyst Ratings
Raymond James Maintains Outperform on AirSculpt Technologies, Raises Price Target to $10
AirSculpt Technologies Analyst Ratings
Airsculpt Technologies, Inc. (AIRS) Receives a Buy From SVB Securities
Raymond James Reaffirms Their Buy Rating on Airsculpt Technologies, Inc. (AIRS)
AirSculpt Technologies Analyst Ratings
Morgan Stanley Maintains Equal-Weight on AirSculpt Technologies, Lowers Price Target to $6
Morgan Stanley Sticks to Its Hold Rating for Airsculpt Technologies, Inc. (AIRS)
Morgan Stanley Adjusts Price Target on AirSculpt Technologies to $7 From $11, Maintains Equal-Weight Rating
AirSculpt Technologies Analyst Ratings
Morgan Stanley Maintains Equal-Weight on AirSculpt Technologies, Lowers Price Target to $7
Raymond James Adjusts AirSculpt Technologies' Price Target to $10 From $18, Keeps Outperform Rating
No Data